Pro Brands

918M Wireless Fitness Devices by 2030: Where Brands Must Bet

The wireless fitness device market hits 918.6M units by 2030. Here's where mid-size brands must invest before platform giants lock up distribution.

Three sleek wireless fitness devices in silver and charcoal arranged on warm cream linen.

The global wireless health and fitness device market is on track to reach 918.6 million units by 2030, growing at an 11.4% compound annual growth rate, according to a November 2026 GlobeNewswire report. That's not a forecast you read and file away. For fitness brands outside the top tier, it's a strategic forcing function with a hard deadline.

The question isn't whether connected hardware matters. It clearly does. The question is where a mid-size fitness brand can build a position that Apple, Abbott, or Adidas won't absorb within three product cycles.

Who's Already at the Table

The report names Apple, Abbott, Adidas, Bosch, and ASUS as key competing players. That list alone tells you something important: this market has stopped being a pure fitness category. Consumer electronics giants, medical device manufacturers, and sportswear conglomerates are all converging on the same hardware shelf.

Apple controls the premium wrist-based ecosystem. Abbott owns continuous glucose monitoring at clinical scale. Adidas brings decades of athlete trust and retail distribution. Bosch and ASUS represent the hardware manufacturing and chip integration angle. If you're a fitness brand with $50 million in revenue and no proprietary sensor IP, competing head-to-head on device unit economics is not a strategy. It's a budget line that disappears.

This convergence mirrors what's already happening at the partnership level. The WHOOP x F1 deal signals exactly this dynamic for fitness brands: elite data credibility, not hardware margin, is becoming the defensible asset.

The Three Growth Drivers. and What They Actually Cost

The report identifies three primary drivers behind the 918.6 million unit projection: AI-powered wearables, remote health monitoring, and deep smartphone integration. Each one demands a different capital allocation strategy, and conflating them is how brands waste two years building the wrong thing.

AI-powered wearables require ongoing investment in proprietary algorithms and training datasets. The hardware is almost secondary. What creates lock-in is the model that sits behind the device, and how much better it gets with every additional user. If you don't have the user base to train a meaningful model, you need a partnership or licensing deal with someone who does.

Remote health monitoring is the highest-stakes layer. It's pulling fitness brands toward clinical and insurance markets that operate on different regulatory timelines and reimbursement logic. The upside is real: B2B contracts with insurers and employers generate recurring revenue at margins hardware never will. But entry requires either FDA clearance, credible clinical validation, or a partnership with a healthcare system willing to co-develop.

Smartphone integration is the most accessible layer, and therefore the most crowded. Building an SDK or API layer that plugs into existing phone hardware sidesteps manufacturing costs entirely. But it also means your product lives inside Apple's or Google's ecosystem, subject to their platform policies and app store economics. That's a viable entry point, not a durable moat.

Europe Is the Undervalued Expansion Window

While the global wireless device market grows at 11.4% annually, Europe's connected fitness market is projected to grow at 13.2% CAGR through 2035, according to separate market data. That's a meaningful premium above the global average, and it matters if you already have EU distribution infrastructure.

The European expansion opportunity is broader than device sales. Providence Equity's move to build a 900-club European gym network illustrates how institutional capital is positioning around the same demographic trend: an aging, health-conscious European population that's increasingly comfortable with connected health tools.

For fitness brands with existing retail or B2B footholds in the UK, Germany, or the Nordics, the 13.2% CAGR signal warrants accelerating product localization, regulatory preparation under the EU Medical Device Regulation framework, and distributor partnerships before the platform giants consolidate shelf space in those markets.

The Data Layer Is Where Mid-Size Brands Survive

If hardware unit economics are out of reach, the most defensible position for a fitness brand in the next five years is the data and coaching layer. This isn't a consolation strategy. It's arguably the higher-margin play.

Proprietary longitudinal user datasets are genuinely scarce. A brand that has tracked 500,000 users across sleep, activity, recovery, and nutrition for three or more years holds an asset that no new entrant can replicate quickly. That dataset becomes the foundation for three distinct revenue streams: proprietary coaching algorithms, B2B licensing to insurers and self-insured employers, and academic or pharmaceutical research partnerships.

The B2B insurance angle in particular is accelerating. US employers spent over $950 per employee annually on wellness programs in recent years, and that figure keeps rising. Fitness brands that can demonstrate measurable outcomes through longitudinal data. reduced sick days, lower cardiovascular risk markers, improved retention. have a credible sales story to HR buyers that pure hardware manufacturers don't.

This is also where the longevity angle becomes commercially useful. Research increasingly ties basic fitness metrics to long-term health outcomes. Grip strength, for example, quietly predicts lifespan with surprising precision. Brands that build assessment tools around validated biomarkers like this can position their data layer as clinical-adjacent without requiring full FDA clearance.

The Acquisition Alternative

Building from scratch isn't the only path. The fitness and wellness sector has entered a period of aggressive consolidation, and mid-size brands with strong user bases are attractive acquisition targets or acquirers depending on their balance sheet.

The strategic logic is straightforward: buy the capability you can't build in time. A connected apparel brand without algorithm expertise acquires a small AI health startup. A gym software company buys a wearable hardware startup to close the hardware-software loop. A supplement brand with high consumer trust acquires a health monitoring app to extend the relationship beyond the purchase moment.

Supplement M&A activity in 2026 already reflects this logic at billion-dollar scale. The same pattern is spreading into the device and software layer. Brands that wait for the market to stabilize before making acquisition moves will find that valuations have reset upward and the best targets are already off the table.

The merger environment also rewards brands that have built clean, portable data infrastructure. The $7.5B Playlist-EGYM merger demonstrated how quickly fitness tech consolidation can reshape an entire segment. Brands without interoperable data systems will face integration costs that kill deal economics.

What You Should Be Deciding Right Now

The 918.6 million unit projection is a market size number, not a strategy. Here's how to convert it into a decision framework.

  • Assess your data asset honestly. How many longitudinal users do you have. How long have you tracked them. What behavioral and biometric signals do you hold. That inventory determines whether your competitive position lives in the data layer or requires a partnership to get there.
  • Pick one growth driver and go deep. AI wearables, remote monitoring, and smartphone integration each require different partnerships, regulatory paths, and capital. Trying to pursue all three simultaneously is how mid-size brands fragment their product roadmap and lose clarity with both customers and investors.
  • Map the European timeline. If you have EU distribution, the 13.2% CAGR through 2035 is a concrete reason to accelerate localization and regulatory preparation now, before Q4 2027 when platform giants will likely increase European market spend.
  • Define your hardware ceiling. Be explicit about the device investment level above which you're competing on unit economics with Apple and Adidas. Set that ceiling, and redirect capital above it toward data infrastructure, algorithm development, or strategic acquisition.
  • Build toward B2B revenue. Consumer hardware margins are thin and getting thinner. Employer wellness contracts, insurer partnerships, and licensing deals offer recurring revenue with far less price sensitivity. Start building those sales relationships before your product is ready to sell. The procurement cycles are long.

The Window Is Real but Narrow

Platform giants don't move slowly forever. Apple has already expanded Health into clinical trial infrastructure. Google's health data ambitions are well-documented. The 2025 to 2028 window is genuinely open for mid-size brands to establish data moats, secure B2B contracts, and lock in distribution relationships that become much harder to displace once the dominant players have converted their hardware user bases into subscription health ecosystems.

The 918.6 million unit market isn't the prize. The recurring revenue from the people using those devices is. Brands that understand that distinction early enough will build the right infrastructure. Those that don't will find themselves manufacturing hardware at margin for a platform they don't control.